SEIC:NASDAQSEI Investments Company Analysis
Data as of 2026-04-30 - not real-time
$90.87
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
SEI Investments (SEIC) trades at $90.87, roughly 14% above the DCF‑derived fair value of $79.87, yet still below the consensus 12‑month target median of $107. The stock shows a bullish MACD (line $3.13 above signal $1.74) but an elevated RSI of 71, indicating short‑term overbought conditions and proximity to the $92.87 resistance level. Volatility remains high at 31% over the past 30 days and beta is modest at 0.86, suggesting the share moves slightly less than the market but with sizable price swings.
Fundamentally, SEIC delivered a strong Q1 2026, posting 12.9% YoY revenue growth to $622 million and a 23% jump in adjusted EPS to $1.44, beating analyst expectations. Margins are robust (gross 78%, operating 30%, profit 31%) and ROE stands at an impressive 29.6%, while free cash flow of $405 million supports a sustainable dividend yield of 1.11% with a low 17% payout ratio.
Fundamentally, SEIC delivered a strong Q1 2026, posting 12.9% YoY revenue growth to $622 million and a 23% jump in adjusted EPS to $1.44, beating analyst expectations. Margins are robust (gross 78%, operating 30%, profit 31%) and ROE stands at an impressive 29.6%, while free cash flow of $405 million supports a sustainable dividend yield of 1.11% with a low 17% payout ratio.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI of 71 signals overbought pressure
- Price near resistance at $92.87
- High short‑term volatility (31%)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Q1 earnings beat with 12.9% revenue growth
- Strong profitability and ROE
- Upside potential of ~14% to DCF fair value and further to analyst targets
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend supported by cash flow
- Strategic partnerships and expanding IMS platform
- Consistently high margins and capital efficiency
Key Metrics & Analysis
Financial Health
Revenue Growth12.80%
Profit Margin31.17%
P/E Ratio15.5
ROE29.63%
ROA14.00%
Debt/Equity2.52
P/B Ratio4.5
Op. Cash Flow$682.8M
Free Cash Flow$404.6M
Industry P/E17.5
Technical Analysis
TrendNeutral
RSI71.1
Support$75.08
Resistance$92.87
MA 20$81.91
MA 50$80.59
MA 200$83.87
MACDBullish
VolumeIncreasing
Fear & Greed Index88.14
Valuation
Fair Value$79.87
Target Price$104.00
Upside/Downside14.45%
GradeFair
TypeGrowth
Dividend Yield1.11%
Risk Assessment
Beta0.86
Volatility31.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.